Patients as research partners in preference studies: learnings from IMI-PREFER

BACKGROUND: There is growing recognition of the importance of patient and public stakeholder involvement (PPI) in patient preference research. However, limited evidence exists regarding the impact, barriers and enablers of PPI in preference studies. The Innovative Medicines Initiative (IMI)-PREFER p...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Meredith Y., Janssens, Rosanne, Jimenez-Moreno, A. Cecilia, Cleemput, Irina, Muller, Mireille, Oliveri, Serena, Simons, Gwenda, Strammiello, Valentina, Huys, Isabelle, Falahee, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080166/
https://www.ncbi.nlm.nih.gov/pubmed/37029449
http://dx.doi.org/10.1186/s40900-023-00430-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080166/
https://www.ncbi.nlm.nih.gov/pubmed/37029449
http://dx.doi.org/10.1186/s40900-023-00430-9

Ejemplares similares